← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2015Last known activity
Nov 4, 2024
Timeline
2000s
- Jun 1, 2004
Aldeyra Therapeutics, Inc.— Founded
2010s
- Jan 29, 2019
Helio Vision— Acquired
Drugs by trial phase (7 distinct, 34 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (34)
- NCT06685692Lead sponsorPhase 2Nov 4, 2024
- NCT06493604Lead sponsorPhase 3Jun 24, 2024
- NCT06424444Lead sponsorPhase 3Apr 29, 2024
- NCT06389214Lead sponsorPhase 3Apr 9, 2024
- NCT05717920Lead sponsorPhase 2Feb 15, 2023
- NCT05599815Lead sponsorPhase 2Dec 31, 2022
- NCT05392179Lead sponsorPhase 2Jul 14, 2022
- NCT05392192Lead sponsorPhase 2Apr 7, 2022
- NCT05424549Lead sponsorPhase 2Mar 9, 2022
- NCT05234554Lead sponsorPhase 3Jan 21, 2022
- NCT05487404Lead sponsorPhase 1/Phase 2Nov 15, 2021
- NCT05102409Lead sponsorPhase 2Sep 9, 2021
- NCT05062330Lead sponsorPhase 3Aug 28, 2021
- NCT04971031Lead sponsorPhase 2Jun 15, 2021
- NCT04908514Lead sponsorPhase 2May 7, 2021
Details
- Founded
- Burlington, MA, US Jun 1, 2004
- Last known activity
- Nov 4, 2024